NASDAQ:SABS

SAB Biotherapeutics, Inc.

Stock

USD

Last Close

2.76

26/07 20:00

Market Cap

29.53M

Beta: 1.26

Volume Today

2.99K

Avg: 1.39M

PE Ratio

−10.36

PFCF: 7.38

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-8.99M -	20.12M 323.87%	-17.14M 185.22%	-17.14M 0%	-42.19M 146.11%
depreciation and amortization	323.41K -	548.18K 69.50%	1.65M 201.65%	1.65M 0%	3.75M 126.49%
deferred income tax	421 -	-2.25K 634.92%			-2.85M -
stock based compensation	371.39K -	1.30M 248.81%	2.31M 78.68%	2.31M 0%	2.42M 4.71%
change in working capital	-923.37K -	-11.95M 1,194.64%	13.45M 212.55%	13.45M 0%	2.33M 82.71%
accounts receivables	-2.56M -	-17.75M 592.60%	12.56M 170.75%	12.56M 0%	5.56M 55.76%
inventory		484.84K -
accounts payables	1.56M -	5.21M 235.14%	-2.94M 156.33%	-2.94M 0%	-2.70M 7.96%
other working capital	84.50K -	100K 18.35%	3.83M 3,731.58%	3.83M 0%	-528.64K 113.80%
other non cash items	1 -	-2 300%	3.48M 173,999,300%	3.48M 0%	11.43M 228.57%
net cash provided by operating activities	-9.21M -	10.00M 208.58%	3.76M 62.43%	3.76M 0%	-25.12M 768.32%
investments in property plant and equipment	-608.75K -	-12.73M 1,991.46%	-10.94M 14.04%	-10.94M 0%	-197.15K 98.20%
acquisitions net		9K -		76.39K -	44.45K 41.81%
purchases of investments
sales maturities of investments
other investing activites				-76.39K -
net cash used for investing activites	-608.75K -	-12.72M 1,989.98%	-10.94M 13.98%	-10.94M 0%	-152.70K 98.60%
debt repayment	-623.27K -	-1.58M 153.42%	-227.27K 85.61%	-227.27K 0%	-390.44K 71.80%
common stock issued		9.90M -	6.75K 99.93%	76.97K 1,040.31%	67.16M 87,158.29%
common stock repurchased				-5.52M -
dividends paid
other financing activites	4.30M -	661.61K 84.63%	34.34M 5,090.39%	39.79M 15.87%	59.40M 49.28%
net cash used provided by financing activities	3.68M -	8.98M 143.98%	34.12M 279.85%	34.12M 0%	66.77M 95.70%
effect of forex changes on cash					18.14K -
net change in cash	-6.14M -	6.26M 202.00%	26.93M 329.96%	26.93M 0%	41.52M 54.15%
cash at beginning of period	12.49M -	6.35M 49.18%	12.61M 98.71%	12.61M 0%	15.05M 19.32%
cash at end of period	6.35M -	12.61M 98.71%	39.55M 213.59%	39.55M 0%	56.57M 43.04%
operating cash flow	-9.21M -	10.00M 208.58%	3.76M 62.43%	3.76M 0%	-25.12M 768.32%
capital expenditure	-608.75K -	-12.73M 1,991.46%	-10.94M 14.04%	-10.94M 0%	-197.15K 98.20%
free cash flow	-9.82M -	-2.73M 72.24%	-7.19M 163.49%	-7.19M 0%	-25.32M 252.35%

All numbers in USD (except ratios and percentages)